These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11979837)

  • 1. [The analysis of the recurrence ulcer after H. pylori eradication].
    Kamada T; Chayama K; Haruma K; Yoshihara M; Ito M; Kitadai Y; Kawamura Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():501-5. PubMed ID: 11979837
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Helicobacter pylori infection in peptic ulcer disease].
    Takeda H; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():13-8. PubMed ID: 11979764
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of H. pylori eradication in NSAIDs ulcer].
    Kato M; Ono S; Mabe K; Shimizu Y; Asaka M
    Nihon Rinsho; 2011 Jun; 69(6):1049-56. PubMed ID: 21688626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
    Ota S; Nakajima S; Bamba H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
    Shimada T; Yamagata M; Hiraishi H
    Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ„ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of Helicobacter pylori-negative peptic ulcer].
    Takagi A; Kobayashi K; Deguchi R
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():613-6. PubMed ID: 16363612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of H. pylori eradicated patients during more-than-5-year follow-up].
    Kato M; Shimizu Y; Nakagawa S; Kodaira J; Takei M; Furukawa S; Yamamoto F; Takano M; Nagasako T; Nakaya H; Kato T; Oda H; Okawara T; Mizushima T; Komatsu Y; Takeda H; Sugiyama T; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():491-6. PubMed ID: 11979834
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
    Maiden LP; Harris AW
    N Engl J Med; 2002 Nov; 347(20):1623-4; author reply 1623-4. PubMed ID: 12432054
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term follow-up after H. pylori eradication].
    Kato M; Shimizu Y; Rinan Z; Takeda H; Asaka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():491-4. PubMed ID: 16363586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peptic ulcer recurrence after successful eradication of Helicobacter pylori--clinical characteristics and management].
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Nihon Rinsho; 2004 Mar; 62(3):495-8. PubMed ID: 15038093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage in ulcer study.
    Bobrove AM
    Hosp Pract (1995); 1998 Jun; 33(6):46. PubMed ID: 9636350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].
    Sakaki N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():471-6. PubMed ID: 11979830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastric ulcer is one of the diseases for which Helicobacter pylori eradication is recommended].
    Satoh K
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():259-63. PubMed ID: 16363541
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T; Uribe RU; Kubota T; Murakami K; Kawasaki H; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.